Assessment of serum protein electrophoresis for monitoring therapy of naturally acquired equine cyathostomin infections.

The research paper describes a study aimed at assessing the effectiveness of Serum Protein Electrophoresis (SPE) as a tool for monitoring the treatment of horse worm infections. It was found that SPE did not efficiently detect changes in protein after treatment, concluding that it is an insensitive method for tracking worm treatment progress in horses.

Study Overview

• The study involved a population of 38 horses that were naturally infected with cyathostomins, a common parasite found in horses.
• These horses were divided into three groups each receiving different treatments: Fenbendazole was given to Group F, Moxidectin to Group M, and Pyrantel to Group P.
• The worm load was measured in fecal samples obtained on specific days, whereas the efficacy of the anthelmintics (medicine to treat worm infections) was evaluated by a Faecal Egg Count Reduction Test (FECRT).
• As the worms infecting the horses were found to be resistant to Fenbendazole (given to Group F), this group served as a control for comparing changes in protein fractions post-treatment.
• Protein composition in horse blood was measured using Serum Protein Electrophoresis (SPE), a technique to separate proteins based on their charge and size.

Primary Findings

• The study found a high anthelmintic efficacy of Moxidectin and Pyrantel.
• It was identified that the cyathostomins were highly resistant to Fenbendazole.
• The serum proteins did not vary significantly among the three groups on any of the sampling dates.
• There were no significant changes or patterns observed in the serum proteins of any of the groups during the post-treatment monitoring.

Conclusion

• The study concluded that Serum Protein Electrophoresis (SPE), the method proposed for monitoring the success of treatments, was ineffective in this setting.
• It was highlighted that no substantial changes were detected in the serum proteins post-treatments, indicating that SPE is not a reliable tool for monitoring cyathostomin treatment in horses in a clinical scenario.